TOTH GERGELY (Chief Executive Officer) received a stock award from CANTABIO PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 4 awards
Filed: 10/11/2018ACC: 0001648371-18-000001
DirectorOfficer10% Owner· Chief Executive Officer
Since Dec 2015
+9.93M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
23.43M acquired · 13.50M disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−13.50M
Price / share
—
Trade value
—
% of position
New position
12/17/2015
13.50M→0.00
Common Stock
Direct
Shares
+10.08M
Price / share
—
Trade value
—
% of position
New position
12/17/2015
0.00→10.08M
Common Stock
Direct
Shares
+2.40M
Price / share
—
Trade value
—
% of position
23.8%
3/27/2018
10.08M→12.48M
Common Stock
Direct
Shares
+3.60M
Price / share
—
Trade value
—
% of position
28.8%
4/1/2018
12.48M→16.08M
Common Stock
Direct
Shares
+7.35M
Price / share
—
Trade value
—
% of position
45.7%
9/12/2018
16.08M→23.43M
Total
Net shares
+9.93M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2015 | D · Disposition | −13.50M | — | — | New position | 13.50M | 0.00 |
| Common Stock Direct | 12/17/2015 | A · Award | +10.08M | — | — | New position | 0.00 | 10.08M |
| Common Stock Direct | 3/27/2018 | A · Award | +2.40M | — | — | 23.8% | 10.08M | 12.48M |
| Common Stock Direct | 4/1/2018 | A · Award | +3.60M | — | — | 28.8% | 12.48M | 16.08M |
| Common Stock Direct | 9/12/2018 | A · Award | +7.35M | — | — | 45.7% | 16.08M | 23.43M |
| Total | +9.93M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported